9,10-dimethyl-1,2-benzanthracene has been researched along with Cockayne Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beems, RB; Berg, RJ; Bootsma, D; de Boer, J; de Gruijl, FR; de Wit, J; Garssen, J; Hoeijmakers, JH; van der Horst, GT; van Kreijl, CF; van Oostrum, CT; van Steeg, H; Weeda, G | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Cockayne Syndrome
| Article | Year |
|---|---|
Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alleles; Animals; Cockayne Syndrome; Disease Models, Animal; DNA Helicases; DNA Repair; DNA-Binding Proteins; Fibroblasts; Gene Targeting; Genetic Predisposition to Disease; Growth Disorders; Hair Diseases; Humans; Hyperplasia; Ichthyosis; Mice; Mice, Inbred C57BL; Neoplastic Syndromes, Hereditary; Point Mutation; Proteins; Radiation Tolerance; Skin; Skin Neoplasms; Transcription Factor TFIIH; Transcription Factors; Transcription Factors, TFII; Transcription, Genetic; Ultraviolet Rays; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group D Protein | 1999 |